Shares of Hims & Hers Health (NYSE:HIMS) are under pressure after JPMorgan trimmed its price target on the consumer ...

We recently published 10 Stocks Stealing Today’s Spotlight; 5 on All-Time Highs. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best performers on Wednesday. Hims & Hers soared by 16.18 percent on ...

Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus Hims & Hers Health (NYSE:HIMS) reported ...

Hims & Hers Health stock plummeted after an FDA decision that prevents the company from selling compounded semaglutide. The company still expects to deliver strong revenue growth, though, and plans to ...

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...

A veteran of several companies within highly regulated industries has has joined Hims & Hers as chief communications officer. Kathryn Beiser joins the San Francisco-based health and wellness platform ...

Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton discuss some of Monday's top trending stories. Ticketmaster parent company Live Nation (LYV) reached a settlement in ...

As the Super Bowl approached halftime, Hims & Hers publicly staked its claim to preventive medicine in front of the American people. In a one-minute ad, the direct-to-consumer health company ...

Hims & Hers Health, Inc. HIMS launched a new specialty in women’s health last week. It offers access to affordable treatment plans built specifically for women experiencing perimenopause and menopause ...